Mar. 10 at 4:43 PM
PRISM Mid-Day Movers: Global Health and Biotech are Today’s Leaders.
Longeveron (NASDAQ:
$LGVN ) is ripping ~71% as traders crowd into its stem‑cell story after Phase 2b data showed lead therapy laromestrocel improved 6‑minute walk distance by 63m in frail elderly patients and MRI biomarker work in Alzheimer’s pointed to reduced neuroinflammation, while new financing extends cash into late 2026.
Polaryx Therapeutics (NASDAQ:
$PLYX ) adds another ~22–23% to
$3.52 as its thin float, fresh Nasdaq direct listing, Maxim
$10 Buy rating, and plans for the SOTERIA Phase 2 basket trial of PLX‑200 across multiple lysosomal storage disorders keep momentum money pressing the bid.
Other Notable Movers:
LifeMD(
$LFMD) up 20%
Hepion Pharmaceuticals (
$HEPA) up 19%
Allurion (
$ALUR) down -45%
https://prismmarketview.com/prism-mid-day-movers-global-health-and-biotech-are-todays-leaders/